Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
02/28/1990 | EP0355604A2 Anti-cancer activity potentiator |
02/28/1990 | EP0355570A2 Preparation for the preservation of microbially perishable products |
02/28/1990 | EP0355470A2 Pharmaceutical form with sustained release, and process for its preparation |
02/28/1990 | EP0355348A2 Superoxide dismutase composition |
02/28/1990 | EP0355142A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
02/28/1990 | EP0355140A1 Human monoclonal anti-hiv-i-antibodies |
02/28/1990 | EP0355097A1 Substituted cyclic complex-forming substances, complexes and complex salts, process for manufacturing same, and pharmaceutical agents which contain them |
02/27/1990 | US4904699 Nifedipine concentrate stabilized against the influence of light and a process for its preparation |
02/27/1990 | US4904584 Erythropoietin or a colony stimulating factor having lysine replacements and at least one polyoxyalkylene glycol moiety; solubility; pharmacokinetics |
02/27/1990 | US4904582 Novel amphiphilic nucleic acid conjugates |
02/27/1990 | US4904480 Radiation compatible iodine formulation |
02/27/1990 | US4904467 Stabilized interleukin-2 |
02/27/1990 | CA1266344A1 High molecular compounds having amino groups, and their utilization |
02/27/1990 | CA1266235A1 Tablet composition for drug combinations |
02/22/1990 | WO1990001558A1 Enzyme controlled release system |
02/22/1990 | WO1990001339A1 Detection and treatment of infectious and inflammatory lesions |
02/22/1990 | WO1990001334A1 Formulations for plasminogen activator using aspartate |
02/22/1990 | WO1990001333A1 METHOD FOR PREPARING tPA COMPOSITIONS |
02/22/1990 | WO1990001332A1 Plasminogen activator-heparin conjugates |
02/22/1990 | WO1990001329A1 Enteric formulations of physiologically active peptides and proteins |
02/22/1990 | WO1990001320A1 Water soluble branched beta cyclodextrin steroid complex |
02/22/1990 | WO1990001269A1 Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances |
02/22/1990 | DE3828156A1 Stable aqueous solution of fluorouracil |
02/22/1990 | DE3823070A1 Self-adhesive plaster |
02/21/1990 | EP0355068A2 Recombinant hybrid immunoglobulin molecules and their use |
02/21/1990 | EP0355009A1 Silver sulfadiazine containing pharmaceutical product for the local external therapy |
02/21/1990 | EP0354948A1 Crosslinked hydrophilic copolymer for medical and paramedical use |
02/21/1990 | EP0321474A4 Water soluble complex of a poly(vinylpyrrolidone) copolymer and d-threo-(1,1'-dihydroxy-1-p-nitrophenylisopropyl) dichloroacetamide. |
02/21/1990 | CN1006889B Inclusion compiex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient |
02/20/1990 | US4902682 W/O cream containing hydrocortisone diester |
02/20/1990 | US4902676 Compositions comprising N,N-dialkylalkanamides |
02/20/1990 | US4902516 With coating of poly-3-hydroxybutyrolactone; drug delivery |
02/20/1990 | US4902515 Polylactide compositions |
02/20/1990 | US4902506 Immunogenic conjugates |
02/20/1990 | US4902505 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
02/20/1990 | US4902502 Preparation of a polymer/interleukin-2 conjugate |
02/20/1990 | US4902501 Pharmaceutical compositions endowed with sequestering activity for the biliary acids, containing colestyramin as their active principle, and process for preparing them |
02/20/1990 | US4902500 Polyoxypropylene-polyoxyethylene block polymer and phospholipid |
02/20/1990 | US4902495 Immunotoxin for detection of mast cell abnormalities |
02/20/1990 | EP0357724A4 Stabilized heparin solution. |
02/15/1990 | DE3826962A1 Pharmaceutical composition for oral administration containing non-absorbable metal complexing agents |
02/14/1990 | EP0354855A2 Liposomes on which adsorption of proteins is inhibited |
02/14/1990 | EP0354729A2 Cytotoxic drug conjugates |
02/14/1990 | EP0354728A2 Cytotoxic drug conjugates |
02/14/1990 | EP0354502A1 Indomethacin injections and their production method |
02/14/1990 | EP0354442A1 Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances |
02/13/1990 | US4900780 Acellular resuscitative fluid |
02/13/1990 | US4900775 Single step method for increasing the solubility of herbicides, pesticides, and drugs |
02/13/1990 | US4900734 Novel pharmaceutical composition containing estradiol and progesterone for oral administration |
02/13/1990 | US4900730 Preparation which promotes the absorption of peptides |
02/13/1990 | US4900559 Glutamic acid hydrochloride reduces hydrolysis |
02/13/1990 | US4900555 Skin permeation enhancer compositions using sucrose esters |
02/13/1990 | US4900549 Process for preparing immunogenic complexes and pharmaceutical composition containing these complexes |
02/13/1990 | US4900546 Bone cement for sustained release of substances |
02/13/1990 | CA1265745A1 Stable freeze-dried preparations of an anticancer platinum complex |
02/08/1990 | WO1990001023A1 Method for solubilizing keratinaceous materials using alkaline hydrogen peroxide solution |
02/08/1990 | DE3921403A1 Verfahren zur herstellung von mittels waessriger polymerdispersionen mit einem film ueberzogenen pharmazeutischen praeparaten und filmueberzugsfluessigkeiten Process for the production of means of aqueous polymer emulsions coated with a film about pharmaceutical preparations and filmueberzugsfluessigkeiten |
02/07/1990 | EP0354186A1 A method of preserving ophthalmic solutions and compositions therefor |
02/07/1990 | EP0353960A2 Polyspecific anti-leukocyte conjugate for detection and treatment of infectious and inflammatory lesions |
02/07/1990 | EP0353896A2 Film - forming gels |
02/07/1990 | EP0353845A1 Sodium chloride in tetrahedronal crystal form and aqueous solution containing the same |
02/07/1990 | EP0353772A2 Psoriasis treatment with TGF-beta2 |
02/07/1990 | EP0353281A1 Method of drying macromolecules |
02/07/1990 | CN1039356A Pharmaceutical composition and process for preparation thereof |
02/06/1990 | US4898920 Adhesive compositions, controlled release compositions and transdermal delivery device |
02/06/1990 | US4898884 Method and composition for treating arthritis |
02/06/1990 | US4898826 Method to solubilize tissue plasminogen activator |
02/06/1990 | US4898729 Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
02/06/1990 | US4898728 Process for production of composition containing lecithin and polyvinylpyrrolidone |
02/06/1990 | CA1265413A1 Process of making gelled cellulose triacetate product |
02/01/1990 | DE3825374A1 Complex of at least one lipophilic acid and mitoxantrone and/or bisantrene |
01/31/1990 | EP0353172A2 Erodible iodine-containing polymer composition |
01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
01/31/1990 | EP0352412A2 Aerosols for inhalation containing esters of retinol and/or retinoic acid |
01/31/1990 | EP0352360A1 External preparations free of discoloration |
01/30/1990 | US4897384 Aminoglycoside, ligand |
01/30/1990 | US4897355 Lipisome-polyanion complex |
01/30/1990 | US4897353 Cryogenic protection of phosphofructokinase using amino acids and zinc ions |
01/30/1990 | US4897267 Microparticles comprising a biodegradable polymer controlling the release of an antimalaria active principle, pharmaceutical compositions comprising it and process for its preparation |
01/30/1990 | US4897256 Aerosols |
01/30/1990 | CA1265142A1 Procaterol stabilization |
01/30/1990 | CA1265136A1 Derivatives of 4-desacetyl indole-dihydroindole alkaloids |
01/30/1990 | CA1265135A1 Hydrazide imide derivatives of indole-dihydroindole alkaloids |
01/30/1990 | CA1265052A1 Absorption enhancing agents |
01/30/1990 | CA1265009A1 Initiating reperfusion treatment when heart attack symptoms are present |
01/25/1990 | WO1990000407A1 Oxazolidinone penetration enhancing compounds |
01/25/1990 | WO1990000405A1 Immunoconjugates for cancer diagnosis and therapy |
01/25/1990 | WO1990000397A1 A pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
01/25/1990 | WO1990000393A1 Topical hematoporphyrin |
01/24/1990 | EP0352242A2 Test strip for use in occlusive epicutaneous testing to detect contact allergy to formaldehyde |
01/24/1990 | EP0351897A2 Skin penetration system for salts of amine-functional drugs |
01/24/1990 | EP0351808A2 Controlled release formulations of trophic factors in gangliosideliposome vehicle |
01/24/1990 | EP0351651A2 Insulin preparation |
01/23/1990 | US4895875 Succinic anhydride |
01/23/1990 | US4895839 Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids |
01/23/1990 | US4895727 Pharmaceutical vehicles for exhancing penetration and retention in the skin |
01/23/1990 | US4895716 Lactobionic acid, sodium acetate, glycine |
01/23/1990 | EP0294462A4 Protection against aminoglycoside-induced nephrotoxicity. |
01/23/1990 | CA1264670A1 Treatment of skin disorders |
01/23/1990 | CA1264667A1 Process for the preparation of prolonged-action immunotoxins containing a glycopeptide constituent which inactivates ribosomes, modified on its polysaccharide units |